Eleonora Vianello

发表

The Biological Effects of Bilirubin Photoisomers

C. Tiribelli, M. Urbanová, M. Štícha, 2016, PloS one.

Transcriptional pro ﬁ les predict treatment outcome in patients with tuberculosis and diabetes at diagnosis and at two weeks after initiation of anti-tuberculosis treatment

C. Wijmenga, J. Critchley, B. Alisjahbana, 2022 .

Alterations in the Cell Cycle in the Cerebellum of Hyperbilirubinemic Gunn Rat: A Possible Link with Apoptosis?

C. Tiribelli, N. Rosso, S. Gazzin, 2013, PloS one.

In vivo evaluation of biomolecular mechanisms of bilirubin toxicity and pre-clinical therapies.

Eleonora Vianello, 2017 .

Transcriptional profiles predict treatment outcome in patients with tuberculosis and diabetes at diagnosis and at two weeks after initiation of anti-tuberculosis treatment

C. Wijmenga, J. Critchley, B. Alisjahbana, 2022, medRxiv.

Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study

T. Monath, H. Nakaya, R. Ahmed, 2021, The Lancet. Microbe.

Life-long correction of hyperbilirubinemia with a neonatal liver-specific AAV-mediated gene transfer in a lethal mouse model of Crigler-Najjar Syndrome.

M. Giacca, C. Tiribelli, C. Bellarosa, 2014, Human gene therapy.

Histone acetylation as a new mechanism for bilirubin-induced encephalopathy in the Gunn rat

C. Tiribelli, F. Zanconati, A. Dardis, 2018, Scientific Reports.

Impaired resolution of blood transcriptomes through tuberculosis treatment with diabetes comorbidity

C. Wijmenga, J. Critchley, B. Alisjahbana, 2022, medRxiv.

Histone acetylation as a new mechanism for bilirubin-induced encephalopathy in the Gunn rat

C. Tiribelli, F. Zanconati, A. Dardis, 2018, Scientific Reports.

Whole blood RNA signatures in tuberculosis patients receiving H56:IC31 vaccine as adjunctive therapy

R. Mortensen, S. Jenum, A. Dyrhol-Riise, 2024, Frontiers in immunology.

Global blood miRNA profiling unravels early signatures of immunogenicity of Ebola vaccine rVSVΔG-ZEBOV-GP

D. Medaglini, C. Siegrist, A. Harandi, 2023, iScience.